promet links
internal website
Projects related to the
promet objectives
supported by the European Commission
FP7 EU research projects
NANOTHERAPY
A novel nano-container drug carrier for targeted
treatment of prostate cancer
FLUODIAMON
Ultra-high resolution and ultra-sensitive fluorescence methods for
objective sub-cellular diagnosis of early disease and disease progression in
breast and prostate cancer
PROMARK
Genetic prostate cancer variants as biomarkers of disease
progression
PROSPER
Genetic prostate cancer variants as biomarkers of disease
progression
P63 PROSTUMOR
Investigating the role of p63 in PROstate STem cells and tUMOR development
CANCERGENE
Identification and functional characterization of genetic cancer risk variants
EXACTA
Exploring the aggressiveness of prostate cancer to enable an individualised treatment approach
TARGETING_CANCER
Eradication of tumors by targeting dsRNA selectively to cancer cells and recruitment of the innate immune system
EPIDIACAN
Development of sensitive methodologies for exploitation of early epigenetic marker diagnosis in major types of cancer
PRO-NEST
Prostate research organizations-network of early stage training
COMBINE
From flies to humans combining whole genome screens and tissue specific gene targeting to identify novel pathways involved in cancer and metastases
GROWTHCONTROL
Dissecting the transcriptional mechanisms controlling growth during normal development and cancer
EPIGENETIC MARKER
Evaluation of epigenetic biomarkers in prostate cancer patients before and after hormone ablation therapy
COGS
Collaborative oncological gene-environment study
METOXIA
Metastatic tumours facilitated by hypoxic tumour micro-environments
CP-SMARTSURFACES
Towards better point of care devices: Conducting polymers as smart surfaces in biosensors.
AR BF3 BINDERS
Identification of the protein binders of the androgen receptor BF3 pocket, an allosteric modulator of AF2 coactivator recruitment
FP6 EU research projects
ADONIS
Accurate Diagnosis of
prostate cancer using Optoacoustic detection of biologically functionalized gold
Nanoparticles - a new Integrated biosensor System
P-
MARK
A quest for new diagnostic and prognostic markers for prostate
cancer
PRIMA
Prostate Cancer Integral
Management Approach
GIANT
Gene therapy: an integrated approach for neoplastic treatment
CANCURE
CANcer CURe Early stage research training
BACULOGENES
Baculovirus vectors for gene therapy
TAMIRUT
A new bio-sensor concept for medical diagnosis: targeted micro-bubbles and remote ultrasound transduction
EUROCADET
The impact of key determinants on the current and future burden of cancer in Europe
TCAC IN CANCER
Defects in the tricarboxylic acid (KREBS) cycle genes in tumorigenesis
RANK AND BREAST CANC
The Role of RANK and RANKL in breast cancer and metastasis generation of new mouse model for breast cancer research
DENDRITOPHAGES
Therapeutic cancer vaccines
ENACT
European Network for the identification and validation of Antigens and biomarkers in Cancer and their application in clinical Tumour immunology
INVASION SCREENING
Gene silencing-based functional screening for genes regulating invasion in human cancer cells
AIDIT
Advancing International Co-operation and Developing Infrastructure for Targeted Screening of Prostate Cancer in Men with Genetic Predisposition
MMR-RELATED CANCER
Prevention, diagnosis and molecular characterisation of mismatch repair defect-related hereditary cancers of the digestive system
POLYGENE
Inherited risk of breast and prostate cancer
HERMIONE
Novel anticancer therapeutics based on modulation of apoptosis through dependence receptors
CANCERDEGRADOME
Extracellular Proteases and the Cances Degradome: Innovative Diagnostic Markers, Therapeutic Targets and Tumour Imaging Agents
PREDICTIVE DIAGNOSIS
Target activation predicts therapeutic benefit
Other
The "European Randomized study of
Screening for Prostate Cancer"
ERSPC
EU Network of Excellence
EMIL
European
Molecular Imaging Laboratories
European Association of Urology